# T. Rowe Price Health Sciences Fund, Inc.

T. Rowe Price Health Sciences Fund, Inc. is a registered fund series of T. ROWE PRICE HEALTH SCIENCES FUND, INC. (series S000002088). Net assets $10.9B as of 2026-03-31.

## Profile

- Series ID: S000002088
- Registrant: T. ROWE PRICE HEALTH SCIENCES FUND, INC.
- LEI: 66LP7EMLZS5S33LWIH41
- Net assets: $10.9B
- Total assets: $10.9B
- As of: 2026-03-31

## Advisers

- [T. Rowe Price Associates, Inc. (Advisor)](https://search.stillhousedata.com/firm/105496)

## Top holdings (200 reported)

_Showing 15 of 200 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [ELI LILLY & CO](https://search.stillhousedata.com/security/532457108) | — | $1.1B | 1013.62% |
| [THERMO FISHER SCIENTIFIC INC](https://search.stillhousedata.com/security/883556102) | — | $442.9M | 406.54% |
| [INTUITIVE SURGICAL INC](https://search.stillhousedata.com/security/46120E602) | — | $397.9M | 365.30% |
| [STRYKER CORP](https://search.stillhousedata.com/security/863667101) | — | $377.1M | 346.14% |
| [MERCK & CO. INC.](https://search.stillhousedata.com/security/58933Y105) | — | $374.9M | 344.13% |
| ASTRAZENECA PLC | — | $345.4M | 317.06% |
| [UNITEDHEALTH GROUP INC](https://search.stillhousedata.com/security/91324P102) | — | $336.3M | 308.73% |
| [ARGENX SE - ADR](https://search.stillhousedata.com/security/04016X101) | — | $317.9M | 291.82% |
| [ABBVIE INC](https://search.stillhousedata.com/security/00287Y109) | — | $309.6M | 284.18% |
| [REGENERON PHARMACEUTICALS](https://search.stillhousedata.com/security/75886F107) | — | $288.4M | 264.72% |
| [GILEAD SCIENCES INC](https://search.stillhousedata.com/security/375558103) | — | $283.6M | 260.34% |
| [JOHNSON & JOHNSON](https://search.stillhousedata.com/security/478160104) | — | $266.0M | 244.22% |
| [VERTEX PHARMACEUTICALS INC](https://search.stillhousedata.com/security/92532F100) | — | $264.0M | 242.38% |
| [DANAHER CORP](https://search.stillhousedata.com/security/235851102) | — | $222.9M | 204.59% |
| [ALNYLAM PHARMACEUTICALS INC](https://search.stillhousedata.com/security/02043Q107) | — | $176.0M | 161.56% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-03-31 | $10.9B |
| 2025-12-31 | $12.1B |
| 2025-09-30 | $11.0B |
| 2025-06-30 | $11.3B |
| 2025-03-31 | $12.3B |
| 2024-12-31 | $13.0B |
| 2024-09-30 | $15.4B |
| 2024-06-30 | $14.9B |

## More

- [Registrant: T. ROWE PRICE HEALTH SCIENCES FUND, INC.](https://search.stillhousedata.com/registrant/1002624)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000002088.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.